Hubei Biocause Pharmaceutical Co (SZSE:000627) Other Operating Expense : ¥7,106 Mil (TTM As of Mar. 2024)

View and export this data going back to 1996. Start your Free Trial

What is Hubei Biocause Pharmaceutical Co Other Operating Expense?

Hubei Biocause Pharmaceutical Co's Other Operating Expense for the three months ended in Mar. 2024 was ¥-3,829 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥7,106 Mil.

Hubei Biocause Pharmaceutical Co's quarterly Other Operating Expense increased from Sep. 2023 (¥19 Mil) to Dec. 2023 (¥4,247 Mil) but then declined from Dec. 2023 (¥4,247 Mil) to Mar. 2024 (¥-3,829 Mil).

Hubei Biocause Pharmaceutical Co's annual Other Operating Expense declined from Dec. 2021 (¥9,897 Mil) to Dec. 2022 (¥9,826 Mil) but then increased from Dec. 2022 (¥9,826 Mil) to Dec. 2023 (¥17,686 Mil).

Hubei Biocause Pharmaceutical Co Other Operating Expense Historical Data

The historical data trend for Hubei Biocause Pharmaceutical Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hubei Biocause Pharmaceutical Co Other Operating Expense Chart

Hubei Biocause Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Operating Expense

Get a 7-Day Free Trial

30,062.05

33,770.93

9,896.83

9,825.53

17,685.86

Hubei Biocause Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															6,751.24	6,669.20	18.68	4,246.74	-3,828.67

Hubei Biocause Pharmaceutical Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥7,106 Mil.

Hubei Biocause Pharmaceutical Co Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Hubei Biocause Pharmaceutical Co's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Hubei Biocause Pharmaceutical Co (SZSE:000627) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Insurance » Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

2nd Floor, Building 1, No. 1 Tianshan Road, Guohua Huijin Center, Zhanghe New District, Hubei Province, Jingmen, CHN, 448000

Website

http://www.tianmaogroup.net

Hubei Biocause Pharmaceutical Co Ltd is a China-based company engaged in life insurance, health insurance, accident insurance, and other life insurance businesses, medicine, and chemical businesses. The company generates its revenue in the form of premiums.

Executives

Jiang Hai Hua	Independent director
Fu Yong Jin	Directors, executives
Wu Shi Yan	Supervisors

Hubei Biocause Pharmaceutical Co (SZSE:000627) Headlines

No Headlines